MJT & Associates Financial Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.7K Buy
23
+2
+10% +$797 0.01% 197
2026
Q2
$7.61K Hold
21
– – 0.01% 232
2026
Q1
$7.39K Hold
21
– – 0.01% 218
2025
Q4
$6.87K Hold
21
– – 0.01% 244
2025
Q3
$5.93K Hold
21
– – ﹤0.01% 266
2025
Q2
$5.86K Hold
21
– – 0.01% 288
2025
Q1
$6.54K Buy
+21
New +$6.2K 0.01% 269

Other funds holding AMGN

MJT & Associates Financial Advisory's AMGN Position: Q3 2026 in Review

MJT & Associates Financial Advisory increased its Amgen (AMGN) stake by 9.5% in Q3 2026, buying an estimated $797 and bringing the position to 23 shares worth $9.7K. The position accounts for 0.01% of the portfolio, ranked #197.

MJT & Associates Financial Advisory first reported a position in AMGN in Q1 2025 and has held it in 7 quarters since. 104 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • MJT & Associates Financial Advisory held 23 shares of Amgen worth $9.7K as of Q3 2026.
  • MJT & Associates Financial Advisory bought 2 Amgen shares in Q3 2026, an estimated $797.
  • Amgen made up 0.01% of MJT & Associates Financial Advisory's portfolio in Q3 2026, its #197 holding.
  • MJT & Associates Financial Advisory first reported a position in Amgen in Q1 2025 and has held it in 7 quarters since.
  • 104 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q3 2026, filed 7 Oct 2026.